December 20, 2022 News by Patricia Inacio, PhD Frequency Names Advisory Board to Guide Remyelination Work for MS Frequency Therapeutics has established a clinical advisory board, with experts across neuroscience fields, to help guide its small molecule treatment candidate for remyelination inĀ multiple sclerosis (MS) into clinical testing. The company is planning to initiate a first trial of the molecule, designed to boost remyelination ā the…
July 25, 2022 News by Marisa Wexler, MS Heart Medication Digoxin Helps With Remyelination in Early Study Digoxin, an approved medication for certain heart conditions, promoted the repair of myelinĀ ā the protective sheath around nerve fibers that is progressively lost in multiple sclerosis ā in mouse models of the disease, a study reports. Combining digoxin with an experimental immune-modulating therapy was more effective at promoting myelin…
June 14, 2022 News by Marta Figueiredo, PhD Find Therapeutics, SATT Conectus Team to Develop New MS Therapy Find Therapeutics and SATT Conectus have joined forces to develop a promising therapy for multiple sclerosis (MS) and optic neuritis based on a new class of compounds that shows the potential to regenerate myelin. Myelin is the fatty protective sheath around nerve fibers that’s progressively lost…
January 20, 2020 Columns by Ed Tobias MS News that Caught My Eye Last Week: High Cost of MS Meds; MS Progression, Relapse, and DMT Timing; Remyelinating Therapy Trial; Myelin Regeneration Mouse Study Almost Half of MS Patients Change or Stop DMT Due to High Financial Burden, Survey Shows I frequently see reports of this on multiple sclerosis patient websites. People with MS say they’ve been forced to change or even stop their treatment because it costs too much. Some people have…
December 16, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: US Patent for Remyelination Therapy, Tysabri and Inflammation, Canada Funding Mavenclad MetP Pharma Awarded US Patent for Potential Remyelination Therapy Mention remyelination and the reaction from most of us with multiple sclerosis is probably, “How soon?” This announcement makes me hope that it’s now a little sooner. The process combines testosterone with a compound that changes the activity of something…
February 21, 2019 Columns by Tamara Sellman Need to Know: What Is Remyelination? Editor’s note: “Need to Know” is a series inspired by common forum questions and comments from readers. Have a comment or question about MS? Visit our forum. This week’s question is inspired by the forum topicĀ “New MS Therapy Company to Focus on Rejuvenating Coating…
September 17, 2018 Columns by Debi Wilson This Is What Excites Me About Remyelination Therapy Research RemyelinationĀ therapies are on the horizon as an innovative multiple sclerosis (MS) treatment, according to my neurologist. These therapies have been on my radar the last few years, but to hear my neurologist say they could soon be a reality makes me hopeful of the possibilities. To offer a…